Target intelligence / Profile preview

Beneficial gut bacterium

Molecular classification
Other (composite term), Gram-positive bacterial genera (e.g., Lactobacillus, Roseburia), Gram-negative bacterial genera (e.g., Bacteroides), Firmicutes (e.g., Lactobacillus, Roseburia), Actinobacteria (e.g., Bifidobacterium), Bacteroidetes (e.g., Bacteroides)
01

Overview

Beneficial gut bacteria refers to non-pathogenic microbial taxa in the human gastrointestinal tract that contribute to host health through diverse biological functions, including digesting food, synthesizing vitamins, preventing infection, and modulating immune responses. Prominent examples include *Lactobacillus* and *Bifidobacterium* species, as well as butyrate-producing genera like *Roseburia*. Therapeutic interventions may supplement or promote beneficial bacteria via probiotics, prebiotics, microbiome-targeted drugs, or dietary strategies. However, "beneficial gut bacteria" is not a single molecule or receptor and cannot serve as a classical therapeutic target in the context of molecular pharmacology. Note: For structured data, mapping should be to specific bacterial species or genetically defined strains (e.g., "Lactobacillus rhamnosus GG"), not this broad functional group.

Other names
commensal bacteriaprobiotic bacteriagood bacterialactic acid bacteriabifidobacteriabutyrate-producers
02

Mechanism of action

Colonization resistance (inhibiting pathogens); Modulation of host immune responses; Production of antimicrobial metabolites (e.g., bacteriocins); Fermentation of dietary fibers into short-chain fatty acids; Enhancement of gut barrier function

03

Biological functions

Digestion and absorption of nutrientsVitamin synthesis (e.g., vitamin K, B vitamins)Metabolite production (e.g., short-chain fatty acids such as butyrate)Infection prevention (colonization resistance)Immune stimulation and modulationMaintenance of barrier integrityPrevention of intestinal dysbiosis
04

Disease associations

Inflammation (protection from or contribution to disorders such as IBD)Obesity/metabolic syndromeDepression, anxiety, neurodegenerative diseases (gut-brain axis)Colorectal cancer (anti-proliferative effects)Type 2 diabetes (via metabolic effects and GLP-1 stimulation)Allergies (immune modulation)Infectious disease (prevention of pathogenic colonization)
05

Safety considerations

Risk of sepsis in severely immunocompromised or critically ill patients (rare)Translocation and infection from live probiotic supplementation in select populationsUnknown long-term effects of engineered strainsUnpredictable interactions with host and other microbiota
06

Interacting drugs

Probiotic supplements (containing Lactobacillus, Bifidobacterium, etc.)

3 more in the full profile.

07

Biomarkers

Abundance or diversity of key genera (e.g., fecal Lactobacillus, Bifidobacterium, Roseburia)Butyrate and other short-chain fatty acid levelsMicrobial signature in stool microbiome sequencing

Beyond the preview

Go deeper on Beneficial gut bacterium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beneficial gut bacterium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call